Cuorips Raises $19 Million in Private Placement Led by JIC Venture Growth

As part of the deal, Cuorips will issue 619,700 common shares at ¥4,841 per share through a third-party allotment. The share issuance is expected to close on September 28, 2026.

JICVGI Opportunity Fund 1, managed by JIC Venture Growth Investments, will become a new investor in Cuorips and hold a 6.98% stake after the transaction.

Cuorips will incur ¥23.23 million in issuance costs, leaving the company with net proceeds of approximately ¥2.98 billion.

The transaction has been approved by Cuorips’ board and is intended to provide the company with additional funding to support its business growth.

About Cuorips

Cuorips is a Japan-based company focused on developing new therapies using advanced medical and regenerative medicine technologies.

The company is working on iPS cell-derived cardiomyocyte sheets and aims to develop efficient production methods for regenerative medicine products.

Read Also - VinFast Signs 13 Dealer Partnerships to Open 27 New Showrooms Across the Philippines